Wolfe Research Starts LB Pharmaceuticals Inc (LBRX) at Outperform Jul 7, 2026 05:32AM
H.C. Wainwright Reiterates Buy Rating on LB Pharmaceuticals Inc (LBRX) Jun 22, 2026 07:05AM
Clear Street Starts LB Pharmaceuticals Inc (LBRX) at Buy May 26, 2026 04:30PM
H.C. Wainwright Reiterates Buy Rating on LB Pharmaceuticals Inc (LBRX) May 26, 2026 06:54AM
LB Pharmaceuticals Inc (LBRX) Misses Q1 EPS by 17c May 12, 2026 05:45PM


Apr 27, 2026 06:07AM H.C. Wainwright Starts LB Pharmaceuticals Inc (LBRX) at Buy
Apr 10, 2026 09:09AM Craig-Hallum Starts LB Pharmaceuticals Inc (LBRX) at Buy, 'A Schizophrenia-Driven Story With Long-Term Mood Optionality'
Apr 6, 2026 04:08PM LB Pharmaceuticals (LBRX) files for 4.78M share offering by selling stockholders
Mar 27, 2026 06:55AM LB Pharmaceuticals Inc (LBRX) PT Raised to $40 at Stifel After Q4 Results
Jan 21, 2026 08:04AM LB Pharmaceuticals hires Minako Pazdera as general counsel
Jan 9, 2026 02:43AM Roth/MKM Starts LB Pharmaceuticals Inc (LBRX) at Buy
Jan 6, 2026 07:00AM LB Pharmaceuticals names Ellen Rose and Lindsay Beaupre to senior roles
Nov 6, 2025 08:05AM LB Pharmaceuticals reports Q3 financial results after IPO
Oct 6, 2025 06:19AM Leerink Partners Starts LB Pharmaceuticals Inc (LBRX) at Outperform
Oct 6, 2025 03:46AM Piper Sandler Starts LB Pharmaceuticals Inc (LBRX) at Overweight
Oct 6, 2025 02:20AM Stifel Starts LB Pharmaceuticals Inc (LBRX) at Buy
Sep 25, 2025 08:30AM LB Pharmaceuticals adds two directors to board after IPO
Sep 11, 2025 12:19PM LB Pharmaceuticals Opens At $19, IPO Priced At $15